AUTLAutolus Therapeutics plc American Depositary Share

ADRCNasdaq (XNAS)·USD

Identity

Security key: 12067
Ticker: AUTL
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-06-22
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: AUTL

Detail

Enriched 2026-08-14 20:47

Market cap: $564,223,766.32
Shares outstanding (class): 266,155,786
Shares outstanding (weighted): 266,143,286
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 752
Location: LONDON, X0
Homepage: https://www.autolus.com
Description: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Market cap and share counts drift.

Funds holding this security

4 funds · 6 positions · $2.16M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Biotechnology ETF iShares Trust	IBB	$1.82M	0.02%	1,321,681 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$187.6K	0.02%	135,975 NS	FIGI
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$115.3K	0.01%	83,540 NS	FIGI
BlackRock Health Sciences Trust —	—	$32.6K	0.01%	23,620 NS	FIGI
Health Sciences Portfolio PACIFIC SELECT FUND	—	$23.0K	0.01%	16,672 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$19.0K	-0.00%	-13,800 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERAUTL
FIGI_COMPOSITEBBG00KVT05R6
FIGI_SHARE_CLASSBBG00KVT06G6
CIK0001730463
ISINUS05280R1005
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Autolus Therapeutics is a biotech company developing CAR-T cell therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.